ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,859 | -89.7% | 1,169 | -59.5% | 0.00% | -100.0% |
| Q4 2022 | $17,974 | -18.3% | 2,885 | -12.5% | 0.00% | 0.0% |
| Q3 2022 | $22,000 | +22.2% | 3,298 | +13.9% | 0.00% | 0.0% |
| Q2 2022 | $18,000 | +800.0% | 2,895 | +667.9% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 377 | -57.4% | 0.00% | – |
| Q4 2021 | $4,000 | +300.0% | 884 | +820.8% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 96 | +405.3% | 0.00% | – |
| Q2 2020 | $1,000 | – | 19 | +1800.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |